» Articles » PMID: 17283611

Emerging Infections and Pregnancy

Overview
Date 2007 Feb 8
PMID 17283611
Citations 216
Authors
Affiliations
Soon will be listed here.
Abstract

A key component of the response to emerging infections is consideration of special populations, including pregnant women. Successful pregnancy depends on adaptation of the woman's immune system to tolerate a genetically foreign fetus. Although the immune system changes are not well understood, a shift from cell-mediated immunity toward humoral immunity is believed to occur. These immunologic changes may alter susceptibility to and severity of infectious diseases in pregnant women. For example, pregnancy may increase susceptibility to toxoplasmosis and listeriosis and may increase severity of illness and increase mortality rates from influenza and varicella. Compared with information about more conventional disease threats, information about emerging infectious diseases is quite limited. Pregnant women's altered response to infectious diseases should be considered when planning a response to emerging infectious disease threats.

Citing Articles

Association of SARS-CoV-2 Infection during pregnancy with placental weight and histopathologic lesions.

Theiler R, Warring S, Young M, Santos J, Branda M, Quinton R Placenta. 2024; 159():180-186.

PMID: 39736235 PMC: 11745490. DOI: 10.1016/j.placenta.2024.12.017.


Safety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies.

Getahun D, Liu I, Sy L, Glanz J, Zerbo O, Vazquez-Benitez G JAMA Netw Open. 2024; 7(9):e2434857.

PMID: 39298167 PMC: 11413712. DOI: 10.1001/jamanetworkopen.2024.34857.


Vaccination and Therapeutics.

Abdella W, Selim A, Diab S, Qobeia E, Elgazzar A Adv Exp Med Biol. 2024; 1457:165-184.

PMID: 39283426 DOI: 10.1007/978-3-031-61939-7_9.


Perceived stress and life satisfaction in pregnant women during the COVID-19 pandemic: the mediating role of fear of childbirth and self-esteem.

Gerymski R, Dymecka J, Iszczuk A, Bidzan M Health Psychol Rep. 2024; 12(3):197-208.

PMID: 39234025 PMC: 11370735. DOI: 10.5114/hpr/174380.


Association of maternal infection of SARS-CoV-2 and neonatal susceptibility: A retrospective cohort study.

Zhu X, Peng Y, Chen Y, Xue M, Zhang A, Peng Y Vaccine X. 2024; 20:100536.

PMID: 39176179 PMC: 11338988. DOI: 10.1016/j.jvacx.2024.100536.


References
1.
Lam C, Wong S, Leung T, Chow K, Yu W, Wong T . A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome. BJOG. 2004; 111(8):771-4. PMC: 7161819. DOI: 10.1111/j.1471-0528.2004.00199.x. View

2.
Imrie H, McGONIGLE T, Liu D, Jones D . Reduction in erythrocyte complement receptor 1 (CR1, CD35) and decay accelerating factor (DAF, CD55) during normal pregnancy. J Reprod Immunol. 1996; 31(3):221-7. DOI: 10.1016/0165-0378(96)00977-1. View

3.
Wong S, Chow K, Leung T, Ng W, Ng T, Shek C . Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004; 191(1):292-7. PMC: 7137614. DOI: 10.1016/j.ajog.2003.11.019. View

4.
Price M, Fisher-Hoch S, Craven R, McCormick J . A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ. 1988; 297(6648):584-7. PMC: 1834487. DOI: 10.1136/bmj.297.6648.584. View

5.
Szekeres-Bartho J . Immunological relationship between the mother and the fetus. Int Rev Immunol. 2003; 21(6):471-95. DOI: 10.1080/08830180215017. View